USP aspires to be a diverse, inclusive, innovative, and engaging organization that empowers and engages staff and volunteers.
USP has been building trust in medicine for over 200 years.
The goal of the PQM+ Program is to sustainably strengthen medical product quality assurance systems in low and middle-income countries.
The Toolkit is a resource that addresses areas of vulnerability in the medical product supply chain through prevention, detection, and response strategies and actions.
Addressing barriers to the development of complex generics: Understanding challenges and opportunities.
The companies listed are those who donated in the last calendar year.
Your comments on USP’s proposed public standards play a key role in USP’s standards-setting process by helping to shape the content of new and revised standards.
Validated methods and highly-characterized reference standards are critical for accurate and reliable analytical results.
Explore the new Gene Therapy Analytical Guide, an online interactive tool that places quality control solutions at your fingertips.
E&Ls can adversely impact a drug's potency, stability, safety, and/or effectiveness, which makes their analysis critical.
The use of unvalidated methods can lead to incorrect results, misinformation about medicine quality and a range of other harmful consequences.
USP-ID, delivered by Mestrelab Research, is a one-click, automated software solution for identifying, quantifying and labelling a broad range of chemical components in both simple solutions and complex mixtures by qNMR.
One way that USP assists manufacturers who are considering adoption of PCM is with technical guides that can help them ensure quality.
Building upon our deep scientific expertise and standards setting, USP provides the Federal Government with solutions that foster supply chain resiliency, improve health equity and patient safety, and sustainably deploy advanced manufacturing and quality testing processes.
Bolstering medical countermeasures by identifying potential shortages and diversifying supplies of key ingredients and materials for at-risk products.
Harnessing the power of new technologies and data science, we are solving supply chain challenges, identifying vulnerabilities, and advancing regulatory science.
Improving quality and efficiency, diversifying supply chains, and reducing waste
Providing actionable insights and tools to minimize disruptions, drive action, and improve visibility.
Advancing standards, tools, and capabilities for quality biotherapeutics and vaccines.
Developing alternate production routes to optimize efficiency and sustainability, increase supply.
Building quality into product development and manufacturing to reduce risk and protect patients.
